Yahoo Web Search

Search results

    • ProKidney Corp Reports First Quarter 2024 Financial Results

      GuruFocus.com via Yahoo Finance· 46 minutes ago

      Its flagship product, REACT (Renal Autologous Cell ...the prior year, reflecting increased investment in clinical development and quality control. General and administrative expenses decreased ...

    • Q1 2024 Clearside Biomedical Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      The current wet AMD market is driving more than $12 billion annually in sales. While the existing approved therapy are effective, including faricimab and high-dose aflibercept ...